Bolton Securities’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Bolton Securities's ADPT Position: Q3 2026 in Review
Bolton Securities sold out of Adaptive Biotechnologies (ADPT) in Q3 2026, closing a stake of 10,000 shares — an estimated $214K sold.
Bolton Securities first reported a position in ADPT in Q4 2025 and held it in 3 quarters. The position peaked at $214K in Q2 2026. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.
- Bolton Securities reported no remaining Adaptive Biotechnologies position as of Q3 2026 after selling out during the quarter.
- Bolton Securities sold 10,000 Adaptive Biotechnologies shares in Q3 2026, an estimated $214K.
- Bolton Securities first reported a position in Adaptive Biotechnologies in Q4 2025 and held it in 3 quarters.
- Bolton Securities's Adaptive Biotechnologies position peaked at $214K in Q2 2026.
- 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.
Based on Bolton Securities's 13F filing for Q3 2026, filed 12 Nov 2026.